NEW YORK, April 24, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement")...
Read More Details
Finally We wish PressBee provided you with enough information of ( ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Lawsuit Filed by The Rosen Law Firm )
Also on site :
- At least 59 Palestinians killed as Israel escalates Gaza bombardment
- Pope Francis’ funeral to stream on YouTube
- No Way: FBI Assesses That Venezuela Facilitating Migration of Gang Members to US